| 米氮平治疗精神分裂症后抑郁的临床研究 |
| |
| 引用本文： | 毛洪祥,朱伟. 米氮平治疗精神分裂症后抑郁的临床研究[J]. 中国健康心理学杂志, 2009, 17(3): 345-346 |
| |
| 作者姓名： | 毛洪祥 朱伟 |
| |
| 作者单位： | 中国.江苏无锡市精神卫生中心,214151;中国.江苏无锡市精神卫生中心,214151 |
| |
| 摘 要： | 目的观察米氮平治疗精神分裂症后抑郁患者的疗效及副作用。方法符合《中国精神障碍分类与诊断标准》（CCMD-3）精神分裂症后抑郁的诊断。将病例随机分为米氮平组和氟西汀组，治疗6周，采用汉密尔顿抑郁量表（HAMD）、简明精神病量表HPKS、阴性症状量表（SANS）及副反应量表（TESS）评定疗效及药物不良反应。结果米氮平组总有效率85．3％。氟西汀组84．3％。两组均无明显不良反应。结论米氮平治疗精神分裂症后抑郁安全、有效，副反应少。
|
| 关 键 词： | 精神分裂症后抑郁 米氮平 治疗 副反应量表 |
The Study of Mirtazapine in the Treatment of Patients with Post-schizophrenic Depression. |
| |
| Mao Hongxiang,Zhu Wei. The Study of Mirtazapine in the Treatment of Patients with Post-schizophrenic Depression.[J]. china journal of health psychology, 2009, 17(3): 345-346 |
| |
| Authors: | Mao Hongxiang Zhu Wei |
| |
| Affiliation: | .( Wuxi Mental Health Centre, Wuxi 214151, P. R. China) |
| |
| Abstract: | Objective To observe the efficacy and the side effects of mirtazapine in the treatment of patients with post-schizophrenic depression.Methods Patients according to CCMD-3 criteria of post-schizophrenic depression were randomly assigned to mirtazapine group and fluoxetine group for the treatment of 6 weeks.The efficacy were assessed by HAMD,SPRS and SANS.The side effects were assessed by TESS.Results The overall effective rate was 85.3% in mirtazapine group and 84.3% in fluoxetine group.Conclusion Mirtazapin... |
| |
| Keywords: | Post-schizophrenic depression Mirtazapine Treatment TESS |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
